Equity
-€142,608
Debts exceed assets in financial year 2025.
WARVAN
Lifetime
20 annual accounts with figures on one time axis, 38 filings since 1988peak of €124,882 in 2018
€65,039▼ 17.3%
lowest -€88,658 in 2011
€48,579▲ 364×
peak of €404,607 in 2010
-€142,608▲ €48,579
€394,607▼ 7.6%
peak of 2 FTE in 2014
-not published
Board2 names since 2019
1 director
Documentsfilings and deeds
15-10-202676 days late
2025micro format
Gross margin from €78,691 to €65,039Result from €134 to €48,579Equity from -€191,187 to -€142,608Cash from €43,869 to €72,526
Key points
from the 2025 annual accountsDebts
€394,607 157% of the balance sheet
Financial debts 81%Suppliers 1%Taxes and wages 1%Other 17%
Of this, €50,984 falls due within a year.
Staff
1 employees on 31-12-2025
In 2025, 4 people joined and 3 left.
Liquidity
4.66 was 2.31 in 2024
Short-term debts fell from €95,589 to €50,984.
Filings
38 annual accounts 76 days
Latest accounts filed late: after the legal deadline.
Position in the sector
-€142,608
Less equity than 95% of companies in retail trade. Sector median €40,864 · 25,352 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,795 companies had the same profile as WARVAN has now. Each dot stands for 10 companies, two years later.
91.4%
were still trading
5.4%
stopped another way
2.7%
went bankrupt
Another 0.6% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,795 companies, not a prediction for WARVAN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0434428554
New manager
appointed, resigned · General meeting of 26-08-2019 · Gazette deed
First establishment
Stationsstraat 93, Waregem
Incorporation
published on 09-07-1988 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| WARVAN Waregem | €251,999 | €65,039 | -56.6% | - |
| PHARMA DAIVE Péruwelz | €247,671 | €64,298 | 60.0% | - |
| Apotheek Velghe Ronse Maarkedal | €244,455 | €58,162 | 10.6% | 1 |
| APOTHEEK PENEL Forest | €277,104 | €62,805 | 4.4% | 0.5 |
| APOTEEK DE DECKER Lebbeke | €234,587 | €58,443 | 79.1% | - |
| APOTHEEK HAEGEMANS - MERTENS Herent | €268,422 | €73,120 | 85.2% | 1.6 |
| North Flow Antwerp | €303,640 | €57,945 | 1.5% | - |
These companies have the same main activity as WARVAN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €235,000 and €304,000, founded between 1986 and 1990.
Official details
Source: KBO- Status
- Active since 16-06-1988Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.038.870.3188790 Waregem, since 28-06-1988
- Financial year end
- 31 December
- Peppol
- Reachable since 25-02-2026
Annual accounts 2025
- ≈ €310,000estimated
- €251,999▲ 6.9%
- Employeeson 31-12-2025
- 1
- Filing
- Filed on 15-10-2026
Insights on WARVAN
WARVAN files the micro format. That format states no turnover. The gross margin rose from €58,908 in 2006 to €65,039 in 2025.
The balance sheet grew most from 2010 to 2011 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about WARVAN
- What is the company number of WARVAN?
- The company number of WARVAN is 0434.428.554. The VAT number is the same number with BE in front: BE 0434.428.554.
- Where is WARVAN based?
- The registered office is at Stationsstraat 93, 8790 Waregem.Company details
- What does WARVAN do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of WARVAN?
- Legal form of WARVAN: Coöperatieve vennootschap met beperkte aansprakelijkheid.
- When was WARVAN founded?
- WARVAN was founded on 16-06-1988.
- Is WARVAN still active?
- Yes, WARVAN is an active enterprise in the KBO register.
- How many employees does WARVAN have?
- WARVAN had an average of 0.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does WARVAN fall under?
- In its 2025 annual accounts, WARVAN states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of WARVAN?
- The turnover in financial year 2025 is ≈ €310,000. This figure is estimated from the gross margin of €65,039 and 54 comparable companies (NACE 477). It probably lies between €160,000 and €450,000.
- Is WARVAN profitable?
- In financial year 2025, WARVAN made a profit of €48,579.
- Where can I find the annual accounts of WARVAN?
- WARVAN filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of WARVAN due?
- WARVAN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.